Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • c-Met/HGFR
    (4)
  • Apoptosis
    (2)
  • ALK
    (1)
  • Autophagy
    (1)
  • Discoidin Domain Receptor (DDR)
    (1)
  • E1/E2/E3 Enzyme
    (1)
  • EGFR
    (1)
  • FLT
    (1)
  • NOD
    (1)
  • Others
    (20)
Filter
Search Result
Results for "

proto-oncogene

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    16
    TargetMol | Inhibitors_Agonists
  • Peptide Products
    1
    TargetMol | Peptide_Products
  • Inhibitory Antibodies
    1
    TargetMol | Inhibitory_Antibodies
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Natural Products
    1
    TargetMol | Natural_Products
  • Recombinant Protein
    72
    TargetMol | Recombinant_Protein
  • Antibody Products
    43
    TargetMol | Antibody_Products
Amivantamab
JNJ-61186372, JNJ61186372, JNJ 61186372
T771102171511-58-1
Amivantamab (JNJ-61186372) is a humanized antibody that recognizes epidermal growth factor receptor (EGFR) and MET proto-oncogene (MET), with anticancer and anti-tumor activities, preventing ligand binding to EGFR and MET and receptor dimerization that inhibits downstream signal transduction. Amivantamab can induce Fc-dependent endocytosis of macrophages and antibody-dependent cytotoxicity of natural killer cells, and can be used to study metastatic non-small cell lung cancer.
  • Inquiry Price
7-10 days
Size
QTY
TargetMol | Inhibitor Hot